Follow Celanese to never miss an important update.
Celanese is partnering with VIGOR to build a new system for lightweight joints used in humanoid robots. This move targets the growing robotics industry, where reducing weight without losing strength is a major technical challenge.
While this is a small niche today, it shows the company finding new uses for its specialty materials beyond its traditional automotive and industrial customers. Diversifying into high-tech robotics could help protect profits if demand in older sectors like construction slows down.
Source: Business Wire
Chief Financial Officer Chuck Kyrish and two other senior vice presidents bought a combined $230,000 worth of shares this month. These were open-market purchases, meaning the executives used their own cash to buy stock at current prices rather than just receiving shares as part of their pay.
When multiple top leaders buy shares at the same time, it often suggests they believe the stock is undervalued. Given that the company recently slashed its dividend to pay down debt, these purchases may be a signal from the leadership team that they are confident in the turnaround plan.
Wells Fargo kept its positive rating but cut its target from $80 to $65. Three other firms, including Deutsche Bank and BMO Capital, also lowered their targets this week, bringing the average analyst target to $60. These changes follow the company's decision to cut its dividend and focus on paying down debt. While analysts still see the stock as worth more than its current $46.80 price, they are tempering their expectations as the company works through a difficult period of high interest costs and heavy debt.
Source: Wells Fargo
Celanese reported a strong second quarter, with profits coming in higher than expected. Sales rose 18 percent compared to the previous three months, driven by a 14 percent jump in prices and a 4 percent increase in the amount of chemicals sold. The company saw particularly strong demand in its medical and electronics businesses.
This result is a good sign for the company's turnaround plan. It shows that Celanese can still raise prices and grow its business even while it is aggressively cutting costs and shutting down older plants to pay off debt. If the company can keep this momentum, it will be in a much better position to handle its large interest payments.
See the full quarter, and how our tracked metrics did
Source: 8-K filing
Celanese reached an agreement with its lenders to raise the limit on its debt-to-earnings ratio, a rule known as a financial covenant. The new limit starts at 5.5 times its earnings and will gradually step down over time.
This change is a safety net. It gives the company more room to operate without breaking its loan rules while it works to pay down its $10.7 billion debt load. While it doesn't change how much the company owes, it reduces the risk that a temporary dip in profits would trigger a default on its loans.
Source: 8-K filing
Analysts recently lowered their price targets following the company's latest earnings report. While 11 of 37 analysts rate the stock a buy, the average target of $60 suggests a 29% upside from the current price.
Management has a history of clearing the bar they set, and a recent big jump in earnings suggests their plan to raise prices is working despite a heavy debt load.
| Expectation | |
|---|---|
| EPS | $1.53 |
| Revenue | $2.62B |